SpeakerKeynote speakersProf. Frank JessenUniversity of CologneSpeaker: Stage 2 of Alzheimer's disease: Evidence and relevancePanelist: New horizons in Alzheimer's therapy - opportunities and challenges LinkProf. Charlotte TeunissenAmsterdam University Medical CenterSpeaker: Body fluid biomarkers in the era of treatment of Alzheimer's diseasePanelist: New horizons in Alzheimer's therapy - opportunities and challenges LinkDr. Gil RabinoviciUniversity of California Speaker: Lecanemab in clinical practice: Lessons from the U.S. experiencePanelist: New horizons in Alzheimer's therapy - opportunities and challenges LinkProf. Andreas PapassotiropoulosUniversity of BaselChair: New horizons in Alzheimer's therapy - opportunities and challenges LinkDr. Anke PostAC ImmunePanelist: New horizons in Alzheimer's therapy - opportunities and challenges LinkDr. Tatjana Meyer-HeimStadtspital Waid, Swiss Memory Clinics representativePanelist: New horizons in Alzheimer's therapy - opportunities and challenges LinkProf. Marc Aurel BuscheUniversity of Basel and Universitäre Altersmedizin FELIX PLATTERSpeaker: Early cellular and circuit-level vulnerabilities in Alzheimer’s disease LinkProf. Gilles AllaliLeenaards Memory Center, CHUVChair: Underlying mechanism of dementia LinkProf. Johannes GräffEPFLSpeaker: Memory traces on the chromatin LinkDr. Tomas RyanTrinity College Dublin, IrelandSpeaker: Forgetting as a form of learning LinkProf. Katharina HenkeUniversity of BernSpeaker: Unconscious episodic memory despite severe memory impairment? LinkDr. Lucie BréchetUniversity of GenevaChair: Memory traces LinkParallel sessionsDr. Alessandro BlasimmeETH ZurichSpeaker: Early detection, brain health and ground-state prevention: Ethical and conceptual challenges for cognitive public health LinkProf. Mauricio AvendanoUniversity of LausanneSpeaker: Public policy, cognitive health and dementia: Insights from natural experiments LinkProf. Emiliano AlbaneseWHO Collaborating Center, University of Geneva and Università della Svizzera italianaChair: Public health perspectives of dementia LinkProf. Steffen HeinrichOstschweizer FachhochschuleSpeaker: Requirements for implementing physical activation approaches for people with dementia in care homes to maintain their everyday abilities LinkDr. Christina ZweifelCURAVIVASpeaker: Care for people with dementia in Swiss nursing homes: Legal and financial framework and the diversity of practices LinkProf. Stefan KlöppelUniversity of BernChair: Care aspects of dementia LinkProf. Philipp HomanPsychiatric University Hospital ZurichSpeaker: Capturing cognitive deficits through language analysis LinkDr. Rasita VinayUniversity of ZurichSpeaker: AI-based voice assistants for early dementia LinkProf. Michael KrauthammerUniversity of ZurichChair: AI and data analytics in dementia LinkDr. Ansgar FelbeckerInselspital Bern, Praxis St. GallenSpeaker: Blood based biomarkers: the HbA1c of dementia diagnosis? LinkProf. Paolo ArosioETH ZurichSpeaker: Monitoring neurodegeneration through brain-derived extracellular vesicles in biofluids LinkProf. Julius PoppUniversity of ZurichChair: Blood-based biomarkers - Session organized by the Swiss Memory Clinics LinkWorkshop sessionsProf. Marina BoccardiUniversity of Applied Sciences of Southern SwitzerlandSpeaker: Producing useful evidence – Translation methodology for implementation LinkDr. Kevin RichetinLeenaards Memory Center and Center of Psychiatric Neurosciences, CHUVSpeaker: Success factors for interdisciplinary collaboration in dementia research LinkDr. Kelly OrmondETH-Zurich and Prof. at Stanford School of MedicineSpeaker: Developing patient centered and ethical dementia research LinkDr. Tracy LaabsWyss CenterSpeaker: A case study in translation: from research data to a start-up for a new dementia therapy LinkProf. Andrea VolterraWyss CenterSpeaker: A case study in translation: from research data to a start-up for a new dementia therapy Link